(UPDATE: The NIH provided a response to our comments on August 28, 2019) On July 2, 2019, KEI and UACT submitted comments to the Federal Register notice 84 FR 28063 on the “Prospective Grant of Exclusive Patent License: Lutetium-177 Radiotherapeutics… Continue Reading
On Monday, 24 June 2019, Knowledge Ecology International (KEI) delivered this opening statement at WIPO’s 30th Session of the Standing Committee on the Law of Patents (SCP). The Committee elected a new chair, Sarah Whitehead, United Kingdom of Great Britain… Continue Reading
(UPDATE: The NIH provided a response to our comments on June 18, 2019) On June 7, 2019, KEI and UACT submitted comments to the Federal Register notice 84 FR 23798, on the “Prospective Grant of an Exclusive Patent License: The… Continue Reading
June 14, 2019 Zolgensma, the Novartis brand name for the new $2.1 million gene therapy for treatment of Spinal Muscular Atrophy (SMA), appears to be a remarkable medical breakthrough treatment. It is also, like all of the new cell- and… Continue Reading
One of the reasons why drug companies have fought so hard to block transparency of clinical trial costs is the growing gap between what the public had been told those costs are, and the actual costs, particularly for treatments for… Continue Reading
Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- and gene-therapies and… Continue Reading
At today’s House Oversight Hearing on PrEP, one of issues will be access to Truvada (FTC+TDF), but also Descovy (FEMTRICITABINE+TENOFOVIR ALAFENAMIDE), a two drug combination, that uses TAF instead of TDF, and is less toxic than Truvada. The Goodrx price… Continue Reading
We now keep track of our FOIA requests here. Recent NIH FOIAs: https://www.keionline.org/foia/nih Older logs and pages about selected Freedom of Information Act (FOIA) requests filed by KEI. Centers for Disease Control and Prevention (CDC) March 3, 2015: CDC FOIA… Continue Reading
KEI Advisory on NIST Green Paper RE: Publication of NIST Green Paper on Innovation and Federally-funded R&D Date: Expected Release by NIST on Weds, April 24, 2019 Background On Wednesday, April 24, 2019, The National Institute of Standards and Technology… Continue Reading
On Monday, 1 April 2019, Knowledge Ecology International (KEI) delivered the following oral statement to the Open Session of the 22nd Meeting of the WHO Expert Committee on the Selection and Use of Essential Medicines. The program for the open… Continue Reading